Biotech & pharma
Learning requires rhythmical activity of neurons
28 Sep 2012
Making and breaking heterochromatin
26 Sep 2012
Study of giant viruses shakes up tree of life
17 Sep 2012
Tracking stem cell reprogramming
By By Anne Trafton, MIT News Office | 17 Sep 2012
Probing matters of the heart
By By Anne Trafton | 15 Sep 2012
Deciphering the language of transcription factors
By By Larry Hardesty, MIT News Office | 13 Sep 2012
Genes that suppress tumours vital to regulating blood precursor cells: study
By By Kim Irwin | 12 Sep 2012
Weapon-wielding marine microbes may protect populations from foes
By By Denise Brehm, Civil and Environmental Engineeri | 12 Sep 2012
In some populations, natural antibiotics are produced by a few individuals whose closest relatives carry genes conferring resistance.
Discovery makes sense of molybdenum mystery
By By Quinn Phillips | 10 Sep 2012
Yale team finds fossil DNA not dead in human genome
By By Bill Hathaway | 07 Sep 2012
Yale researchers using sophisticated data mining and statistical models have discovered that many pseudogenes — stretches of fossil DN — may not be quite dead after all
Researchers identify biochemical functions for most of the human genome
By By Anne Trafton, MIT News Office | 06 Sep 2012
Only about 1 per cent of the human genome contains gene regions that code for proteins, raising the question of what the rest of the DNA is doing. Scientists have now begun to discover the answer
Binding sites for LIN28 protein found in thousands of human genes
By By Debra Kain | 05 Sep 2012
Zooming in on bacterial weapons in 3D
03 Sep 2012
Ancient genome reveals its secrets
31 Aug 2012
More sophisticated wiring, not just a bigger brain, helped humans evolve beyond chimps
By By Elaine Schmidt | 29 Aug 2012
Turning on key enzyme blocks tumour formation
By By Anne Trafton, MIT News Office | 28 Aug 2012
Latest articles
Featured articles
The decoupling paradox: Why Wall Street keeps funding AI despite $100 oil
By Axel Miller | 11 May 2026
AI infrastructure stocks continue rallying despite $100 oil as investors bet on productivity gains and semiconductor demand in 2026.
Hybrid bonding gains attention as AI chip packaging demand grows
By Cygnus | 23 Apr 2026
Hybrid bonding is driving AI chip packaging demand as backend technologies gain importance in the semiconductor supply chain.
The agentic transition: how enterprises are scaling AI from pilot to profit
By Cygnus | 22 Apr 2026
AI has entered its execution era. Discover how companies like Valeo and Microsoft are scaling agentic AI systems—from copilots to autonomous workflows driving real business impact.
Post-splashdown: What Artemis II taught us about the ‘deep space wall’
By Axel Miller | 15 Apr 2026
Artemis II splashdown marks a breakthrough in deep space exploration. Discover AVATAR radiation data, Orion’s distance record, and insights shaping NASA’s 2028 Moon mission.
Can aviation go green? The multi-billion dollar race for sustainable fuel
By Cygnus | 10 Apr 2026
Airlines are racing to adopt sustainable aviation fuel, but limited supply and high costs challenge the future of green aviation.
The battery race: who will control the future of electric vehicles?
By Axel Miller | 08 Apr 2026
The global battery race is reshaping the electric vehicle industry, with China, the US, and Europe competing for control over supply chains and technology.
AI vs governments: Who controls the future of intelligence?
By Cygnus | 07 Apr 2026
Governments and AI companies like OpenAI and Anthropic are shaping the future of intelligence amid rising policy conflicts and global competition.
Strait of Hormuz: how one chokepoint controls the global economy
By Axel Miller | 06 Apr 2026
The Strait of Hormuz is a critical global chokepoint. Learn how disruptions impact oil prices, shipping, and the global economy.
The $2 trillion AI infrastructure race: Who will control global compute?
By Cygnus | 06 Apr 2026
AI spending is set to exceed $2 trillion in 2026, driving a global race in data centers, chips, and energy infrastructure.
